Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02YAQ
|
|||
| Former ID |
DIB011889
|
|||
| Drug Name |
GW-974
|
|||
| Synonyms |
GW-282974; GW-2974; GW-449; GW-734; GW-9263; Erb B-2 inhibitor, Glaxo Wellcome
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Terminated | [1] | |
| Company |
Glaxo Wellcome plc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H21N7
|
|||
| Canonical SMILES |
CN(C)C1=NC=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)N(N=C4)CC5=CC=CC=C5
|
|||
| InChI |
1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)
|
|||
| InChIKey |
DYYZXRCFCVDSKD-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 202272-68-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:95273
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010108) | |||
| REF 2 | WO patent application no. 2005,0443,02, Selective erbb2 inhibitor/anti-erbb antibody combinations in the treatment of cancer. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.